alg, clNo, clustsize, no.Trubetskoy Broad, Enrichment, Broad pval, Broad padj, no. Trubetskoy Priortised, Prior pval, Prior padj, Molecular Function, Molecular padj, Biological Function, Biological padj, Diseases, Diseases padj
infomap, 5, 52, 7, Positive, 0.01791885097, 0.03583770194, 0, 0, 0, protein tyrosine kinase activity, 3.65038510016152e-11, peptidyl-tyrosine phosphorylation, 4.84766620213743e-08, autistic_disorder, 0.0087039393956684
, , , , , , , , , , non-membrane spanning protein tyrosine kinase activity, 1.48590543316569e-06, protein autophosphorylation, 0.0035554986368234, autism_spectrum_disorder, 0.0087039393956684
, , , , , , , , , , SH3 domain binding, 1.12908225592614e-05, protein phosphorylation, 0.0037666812566328
, , , , , , , , , , ephrin receptor binding, 0.0004610207534926, regulation of cell adhesion mediated by integrin, 0.0078970914550988
, , , , , , , , , , SH2 domain binding, 0.0049690147404448, cellular response to transforming growth factor beta stimulus, 0.0078970914550988
, , , , , , , , , , signaling adaptor activity, 0.0160446769615948, positive regulation of cell migration, 0.0078970914550988
, , , , , , , , , , scaffold protein binding, 0.0160446769615948, ephrin receptor signaling pathway, 0.0078970914550988
, , , , , , , , , , protein self-association, 0.0160446769615948, epidermal growth factor receptor signaling pathway, 0.0140613291419228
, , , , , , , , , , Fc-gamma receptor signaling pathway involved in phagocytosis, 0.0255387386346005
, , , , , , , , , , response to ethanol, 0.0255387386346005
, , , , , , , , , , signal transduction, 0.0355620112826306
, , , , , , , , , , positive regulation of peptidyl-tyrosine phosphorylation, 0.0355620112826306
, , , , , , , , , , cellular response to lipopolysaccharide, 0.0355620112826306
, , , , , , , , , , negative regulation of inflammatory response to antigenic stimulus, 0.0415115548572141
, , , , , , , , , , signal complex assembly, 0.0424414046509122
, , , , , , , , , , growth hormone receptor signaling pathway, 0.0424414046509122
, , , , , , , , , , growth hormone receptor signaling pathway via JAK-STAT, 0.0424414046509122
, , , , , , , , , , interleukin-6-mediated signaling pathway, 0.0424414046509122
, , , , , , , , , , regulation of cell adhesion, 0.0426315243576683
infomap, 8, 53, 8, Positive, 0.005568026272, 0.01113605254, 3, 0.03763044543, 0.07526089086, glutamate-gated calcium ion channel activity, 0.0005613647823925, embryo development, 0.0001383228368836
, , , , , , , , , , NMDA glutamate receptor activity, 0.0016077181863078, positive regulation of excitatory postsynaptic potential, 0.000511159334372
, , , , , , , , , , positive regulation of synaptic transmission< glutamatergic, 0.0005969669051648
, , , , , , , , , , monoatomic cation transmembrane transport, 0.0006354205319341
, , , , , , , , , , regulation of monoatomic cation transmembrane transport, 0.0020797826545715
, , , , , , , , , , calcium ion transmembrane import into cytosol, 0.0020797826545715
, , , , , , , , , , excitatory chemical synaptic transmission, 0.0020797826545715
, , , , , , , , , , receptor clustering, 0.0022805747146728
, , , , , , , , , , chemical synaptic transmission, 0.0036057455012198
, , , , , , , , , , receptor localization to synapse, 0.0045802149363088
, , , , , , , , , , ionotropic glutamate receptor signaling pathway, 0.0050337061303365
, , , , , , , , , , establishment or maintenance of epithelial cell apical/basal polarity, 0.0080431950320424
, , , , , , , , , , cell-cell adhesion, 0.0192218394711379
, , , , , , , , , , calcium-mediated signaling, 0.0362824172318456
, , , , , , , , , , neurotransmitter receptor localization to postsynaptic specialization membrane, 0.0418276731832992
infomap, 4, 17, 4, Positive, 0.01068299099, 0.02136598197, 3, 0.001488712689, 0.002977425378, protein serine kinase activity, 8.57974684830098e-07, interleukin-1-mediated signaling pathway, 0.0047012017459472
, , , , , , , , , , ATP binding, 0.0001289854967169, intracellular signal transduction, 0.0047012017459472
, , , , , , , , , , MAP kinase kinase activity, 0.0004014720365345, apoptotic process, 0.0047012017459472
, , , , , , , , , , protein serine/threonine kinase activity, 0.0010383238196065, protein phosphorylation, 0.0047012017459472
, , , , , , , , , , MAP kinase activity, 0.0010383238196065, regulation of ossification, 0.0047012017459472
, , , , , , , , , , histone H3S10 kinase activity, 0.0437579323977027, peptidyl-serine phosphorylation, 0.0077557612671666
, , , , , , , , , , histone H3S28 kinase activity, 0.0437579323977027, regulation of DNA-templated transcription, 0.0077557612671666
, , , , , , , , , , cellular response to tumor necrosis factor, 0.0141322749697956
, , , , , , , , , , stress-activated MAPK cascade, 0.0255009961106375
, , , , , , , , , , positive regulation of transcription by RNA polymerase II, 0.0412331559004903
, , , , , , , , , , lipopolysaccharide-mediated signaling pathway, 0.0412331559004903
infomap, 10, 4, 2, Positive, 0.01605307078, 0.03210614156, 0, 0, 0, [], [], [], [], [], []
, , , , , , , , , , , , , , , 
, , , , , , , , , , , , , , , 
alg, clNo, clustsize, no.Trubetskoy Broad, Enrichment, Broad pval, Broad padj, no. Trubetskoy Priortised, Prior pval, Prior padj, Molecular Function, Molecular padj, Biological Function, Biological padj, Diseases, Diseases padj
sgG1, 23, 126, 14, Positive, 0.004397555551, 0.008795111102, 6, 0.005357736523, 0.01071547305, scaffold protein binding, 3.48466015482925e-06, positive regulation of excitatory postsynaptic potential, 8.43918813849805e-07, autistic_disorder, 8.26694951447575e-06
, , , , , , , , , , protein tyrosine kinase activity, 3.48466015482925e-06, positive regulation of synaptic transmission< glutamatergic, 8.99169013103896e-07, autism_spectrum_disorder, 8.26694951447575e-06
, , , , , , , , , , SH3 domain binding, 0.0004384597064208, peptidyl-tyrosine phosphorylation, 4.55069500716879e-06, epilepsy_syndrome, 0.0101973091142188
, , , , , , , , , , NMDA glutamate receptor activity, 0.0013906324267493, social behavior, 0.0018538081191129, schizophrenia, 0.0129001561218393
, , , , , , , , , , ephrin receptor binding, 0.0013906324267493, neuromuscular process controlling balance, 0.00629634365422, intellectual_disability, 0.0129001561218393
, , , , , , , , , , delayed rectifier potassium channel activity, 0.006824939958446, response to ethanol, 0.0129323657969625
, , , , , , , , , , glutamate-gated calcium ion channel activity, 0.006824939958446, cellular response to transforming growth factor beta stimulus, 0.0222620073142801
, , , , , , , , , , non-membrane spanning protein tyrosine kinase activity, 0.0091820559248871, postsynaptic membrane assembly, 0.0222620073142801
, , , , , , , , , , monoatomic cation transmembrane transport, 0.0222620073142801
, , , , , , , , , , ephrin receptor signaling pathway, 0.0222620073142801
, , , , , , , , , , chemical synaptic transmission, 0.0270570711036703
, , , , , , , , , , vocalization behavior, 0.027715629447098
, , , , , , , , , , potassium ion transmembrane transport, 0.0286943593391914
, , , , , , , , , , epidermal growth factor receptor signaling pathway, 0.0463114983945048
sgG1, 20, 20, 0, Positive, 0, 0, 2, 0.03247873497, 0.06495746994, protein tyrosine phosphatase activity, 0.0498625655814108, synaptic membrane adhesion, 3.77497560909001e-05
, , , , , , , , , , regulation of presynapse assembly, 0.0131357107607348
, , , , , , , , , , trans-synaptic signaling by trans-synaptic complex, 0.0131357107607348
, , , , , , , , , , positive regulation of synapse assembly, 0.0244170597867157
, , , , , , , , , , transmembrane receptor protein tyrosine phosphatase signaling pathway, 0.0310710081455842
sgG1, 9, 88, 87, Negative, 0.03796233246, 0.07592466493, 0, 0, 0, cadherin binding, 1.43751802700153e-06, cytoskeleton-dependent cytokinesis, 0.0032652305897409
, , , , , , , , , , actin binding, 6.6458103844639e-05
, , , , , , , , , , actin filament binding, 0.001746313690798
sgG1, 13, 4, 2, Positive, 0.01605307078, 0.03210614156, 0, 0, 0, [], [], [], [], [], []
, , , , , , , , , , , , , , , 
, , , , , , , , , , , , , , , 
alg, clNo, clustsize, no.Trubetskoy Broad, Enrichment, Broad pval, Broad padj, no. Trubetskoy Priortised, Prior pval, Prior padj, Molecular Function, Molecular padj, Biological Function, Biological padj, Diseases, Diseases padj
sgG2, 19, 59, 7, Positive, 0.03407934563, 0.06815869126, 3, 0.04958163302, 0.09916326603, glutamate-gated calcium ion channel activity, 0.0009793440002867, positive regulation of excitatory postsynaptic potential, 1.43035511309003e-05, autistic_disorder, 0.0098205955526166
, , , , , , , , , , NMDA glutamate receptor activity, 0.0027881324089796, positive regulation of synaptic transmission< glutamatergic, 0.0001021521337502, autism_spectrum_disorder, 0.0098205955526166
, , , , , , , , , , neurexin family protein binding, 0.0061739121654437, monoatomic cation transmembrane transport, 0.0013226948640627, intellectual_disability, 0.0301759757902163
, , , , , , , , , , voltage-gated potassium channel activity, 0.0117185702267672, chemical synaptic transmission, 0.0013226948640627, epilepsy_syndrome, 0.0396459094537677
, , , , , , , , , , delayed rectifier potassium channel activity, 0.0124495396400091, potassium ion transmembrane transport, 0.0025247562853743, schizophrenia, 0.0493847461641442
, , , , , , , , , , glutamate binding, 0.0124495396400091, regulation of monoatomic ion transmembrane transport, 0.0025247562853743
, , , , , , , , , , signaling receptor activity, 0.0168460252857527, embryo development, 0.0025247562853743
, , , , , , , , , , voltage-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential, 0.0310246958194742, regulation of monoatomic cation transmembrane transport, 0.0025247562853743
, , , , , , , , , , calcium ion transmembrane import into cytosol, 0.0025247562853743
, , , , , , , , , , excitatory chemical synaptic transmission, 0.0025247562853743
, , , , , , , , , , receptor localization to synapse, 0.0064508125285354
, , , , , , , , , , postsynaptic membrane assembly, 0.0064508125285354
, , , , , , , , , , presynaptic membrane assembly, 0.0064508125285354
, , , , , , , , , , ionotropic glutamate receptor signaling pathway, 0.0082743152453746
, , , , , , , , , , social behavior, 0.0124492062421268
, , , , , , , , , , positive regulation of synapse assembly, 0.0178599077829991
, , , , , , , , , , brain development, 0.0178599077829991
, , , , , , , , , , neuron cell-cell adhesion, 0.0251778903378108
, , , , , , , , , , receptor clustering, 0.0281007530918868
, , , , , , , , , , calcium-mediated signaling, 0.0430135677466815
sgG2, 13, 23, 4, Positive, 0.03125482081, 0.06250964162, 3, 0.003683001473, 0.007366002946, MAP kinase kinase activity, 1.99259390295212e-05, apoptotic process, 0.0062104206162368
, , , , , , , , , , protein serine kinase activity, 1.99259390295212e-05, cellular response to tumor necrosis factor, 0.0062104206162368
, , , , , , , , , , protein serine/threonine kinase activity, 0.0013240518856624, interleukin-1-mediated signaling pathway, 0.0066888669432326
, , , , , , , , , , MAP kinase activity, 0.0030037023977377, regulation of ossification, 0.0076524157096254
, , , , , , , , , , ATP binding, 0.0030037023977377, thyroid gland development, 0.0076524157096254
, , , , , , , , , , regulation of stress-activated MAPK cascade, 0.0076524157096254
, , , , , , , , , , face development, 0.0076524157096254
, , , , , , , , , , regulation of Golgi inheritance, 0.0076524157096254
, , , , , , , , , , chemotaxis, 0.0100495839862889
, , , , , , , , , , intracellular signal transduction, 0.0143435348834788
, , , , , , , , , , Bergmann glial cell differentiation, 0.0171616103193703
, , , , , , , , , , trachea formation, 0.0171616103193703
, , , , , , , , , , ERK1 and ERK2 cascade, 0.0171616103193703
, , , , , , , , , , regulation of early endosome to late endosome transport, 0.0171616103193703
, , , , , , , , , , regulation of DNA-templated transcription, 0.0171616103193703
, , , , , , , , , , protein phosphorylation, 0.0171616103193703
, , , , , , , , , , stress-activated MAPK cascade, 0.0347997814810772
, , , , , , , , , , , , , , , 
, , , , , , , , , , , , , , , 
alg, clNo, clustsize, no.Trubetskoy Broad, Enrichment, Broad pval, Broad padj, no. Trubetskoy Priortised, Prior pval, Prior padj, Molecular Function, Molecular padj, Biological Function, Biological padj, Diseases, Diseases padj
sgG5, 22, 38, 5, Positive, 0.04878336072, 0.09756672144, 0, 0, 0, glutamate-gated calcium ion channel activity, 9.81893697753113e-05, monoatomic cation transmembrane transport, 0.0004445704007792, schizophrenia, 0.0459479579691494
, , , , , , , , , , NMDA glutamate receptor activity, 0.0002853837295, regulation of monoatomic cation transmembrane transport, 0.0006460636181392
, , , , , , , , , , transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential, 0.0155435793399867, calcium ion transmembrane import into cytosol, 0.0006460636181392
, , , , , , , , , , excitatory chemical synaptic transmission, 0.0006460636181392
, , , , , , , , , , ionotropic glutamate receptor signaling pathway, 0.001042305454509
, , , , , , , , , , calcium-mediated signaling, 0.015936827922986
, , , , , , , , , , positive regulation of excitatory postsynaptic potential, 0.0175067915558953
, , , , , , , , , , embryo development, 0.0203353710686392
, , , , , , , , , , regulation of monoatomic ion transmembrane transport, 0.0211129228526531
, , , , , , , , , , excitatory postsynaptic potential, 0.0211129228526531
, , , , , , , , , , regulation of neuronal synaptic plasticity, 0.0256429451652572
, , , , , , , , , , potassium ion transmembrane transport, 0.0370061747227733
, , , , , , , , , , chemical synaptic transmission, 0.0385774423246599
, , , , , , , , , , receptor clustering, 0.0478029442169885
sgG5, 72, 15, 4, Positive, 0.006640549248, 0.0132810985, 3, 0.001013313692, 0.002026627383, protein serine kinase activity, 1.4330417748119e-07, intracellular signal transduction, 0.0014016189229396
, , , , , , , , , , MAP kinase kinase activity, 1.74568027115521e-06, interleukin-1-mediated signaling pathway, 0.0014016189229396
, , , , , , , , , , ATP binding, 1.16964698688797e-05, apoptotic process, 0.0014016189229396
, , , , , , , , , , protein serine/threonine kinase activity, 1.74168423822323e-05, protein phosphorylation, 0.0014016189229396
, , , , , , , , , , MAP kinase activity, 0.0006947607910602, regulation of ossification, 0.0017475872503316
, , , , , , , , , , histone H3S10 kinase activity, 0.0337836978070499, thyroid gland development, 0.0017475872503316
, , , , , , , , , , histone H3S28 kinase activity, 0.0337836978070499, regulation of stress-activated MAPK cascade, 0.0017475872503316
, , , , , , , , , , face development, 0.0017475872503316
, , , , , , , , , , regulation of Golgi inheritance, 0.0017475872503316
, , , , , , , , , , regulation of DNA-templated transcription, 0.0027062292755074
, , , , , , , , , , Bergmann glial cell differentiation, 0.0043786061880786
, , , , , , , , , , trachea formation, 0.0043786061880786
, , , , , , , , , , ERK1 and ERK2 cascade, 0.0043786061880786
, , , , , , , , , , regulation of early endosome to late endosome transport, 0.0043786061880786
, , , , , , , , , , cellular response to tumor necrosis factor, 0.0043786061880786
, , , , , , , , , , stress-activated MAPK cascade, 0.0096310136916215
, , , , , , , , , , lipopolysaccharide-mediated signaling pathway, 0.0179443163985741
, , , , , , , , , , peptidyl-serine phosphorylation, 0.0229745049692076
, , , , , , , , , , insulin-like growth factor receptor signaling pathway, 0.0278107822679485
, , , , , , , , , , chemotaxis, 0.0396567876036804
, , , , , , , , , , thymus development, 0.0396567876036804
, , , , , , , , , , cellular response to lipoteichoic acid, 0.0396567876036804
, , , , , , , , , , defense response to tumor cell, 0.0396567876036804
, , , , , , , , , , outer ear morphogenesis, 0.0396567876036804
, , , , , , , , , , cardiac neural crest cell development involved in heart development, 0.0396567876036804
, , , , , , , , , , response to epidermal growth factor, 0.0396567876036804
, , , , , , , , , , positive regulation of CREB transcription factor activity, 0.0396567876036804
, , , , , , , , , , cellular senescence, 0.0443734376850943
sgG5, 29, 13, 3, Positive, 0.02900913834, 0.05801827667, 2, 0.01413038709, 0.02826077419, negative regulation of dopamine secretion, 0.0392098932816175
sgG5, 69, 4, 2, Positive, 0.01605307078, 0.03210614156, 0, 0, 0, [], [], [], [], [], []
sgG5, 39, 5, 2, Positive, 0.02583482943, 0.05166965887, 0, 0, 0, [], [], [], [], [], []
, , , , , , , , , , , , , , , 
, , , , , , , , , , , , , , , 
alg, clNo, clustsize, no.Trubetskoy Broad, Enrichment, Broad pval, Broad padj, no. Trubetskoy Priortised, Prior pval, Prior padj, Molecular Function, Molecular padj, Biological Function, Biological padj, Diseases, Diseases padj
spectral, 5, 82, 0, Positive, 0, 0, 4, 0.02540692191, 0.05081384383, glutamate-gated calcium ion channel activity, 0.0053375289295329, positive regulation of excitatory postsynaptic potential, 6.22648576453893e-05, intellectual_disability, 0.0378871233950603
, , , , , , , , , , NMDA glutamate receptor activity, 0.0148476499190578, positive regulation of synaptic transmission< glutamatergic, 0.0001105841014313, schizophrenia, 0.0378871233950603
, , , , , , , , , , neurexin family protein binding, 0.0321273184218243, monoatomic cation transmembrane transport, 0.0080555474277357
, , , , , , , , , , embryo development, 0.019207274649125
, , , , , , , , , , regulation of monoatomic cation transmembrane transport, 0.019207274649125
, , , , , , , , , , calcium ion transmembrane import into cytosol, 0.019207274649125
, , , , , , , , , , excitatory chemical synaptic transmission, 0.019207274649125
, , , , , , , , , , chemical synaptic transmission, 0.0208078269268431
, , , , , , , , , , social behavior, 0.0208078269268431
, , , , , , , , , , receptor localization to synapse, 0.0273578783795795
, , , , , , , , , , positive regulation of synapse assembly, 0.0283524407020556
, , , , , , , , , , postsynaptic membrane assembly, 0.0335682307473924
, , , , , , , , , , presynaptic membrane assembly, 0.0335682307473924
